ArticleRegional anesthesia and pain medicine2026
Patients with Ehlers-Danlos syndrome experience reduced effectiveness of lidocaine local anesthetic: a randomized cross-over clinical trial.
Article in Regional anesthesia and pain medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05603741 (Local Anesthetic Response in Ehlers-Danlos Syndrome), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundThe Ehlers-Danlos syndromes (EDS) are a collection of heritable connective tissue disorders. Local anesthetic resistance is commonly reported by patients with EDS, but there is little clinical evidence to support this finding. We hypothesized that patients with EDS would have increased anesthetic resistance using lidocaine compared with healthy controls.
methodsAn interventional study design was used. Participants (total N=135: EDS n=91, healthy n=44) completed a series of sensation tests using a standardized 10 g monofilament following subcutaneous injection with saline or lidocaine at two separate sites on the right forearm in a randomized order. Participants rated their sensation at each site relative to non-anesthetized skin. Sensation was used as a surrogate measure of anesthetic effect. Participant ratings were converted into two measures: (1) a dichotomous variable to represent adequate anesthesia and (2) a delta sensation score. This study was registered on ClinicalTrials.gov (NCT05603741).
resultsDelta sensation scores were not different at 5 min post-injection between EDS and healthy participants (p=0.2), but were significantly different at 15 min (1 (0-2) arbitrary units (a.u.) vs 2 (1-2) a.u; p=0.002) and 30 min (1 (0-2) a.u. vs 2 (1-2) a.u.; p=0.003) post-injection. There was no difference in categorical "anesthesia" at 5 min between EDS and controls (p=0.2). A smaller proportion of EDS experienced "anesthesia" at 15 min (60% vs 84%, p=0.006) and 30 min (53% vs 80%, p=0.003) post-injection compared with healthy controls.
conclusionPatients with EDS experienced increased sensation with lidocaine, suggesting shorter duration of effect of lidocaine local anesthetic. This evidence validates previous patient reports and small case studies suggesting this phenomenon. Healthcare providers should be aware of this reduced effectiveness experienced by patients with EDS, to adjust care accordingly. TRIAL REGISTRATION NUMBER: NCT05603741.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.